Journal of Medicinal Chemistry
Page 6 of 13
Phosphorylation of p62 activates the Keap1ꢀNrf2 pathway during
selective autophagy. Mol. Cell 2013, 51, 618ꢀ631.
9) Hayashi, K.; Dan, K.; Goto, F.; Tshuchihashi, N.; Nomura, Y.;
Fujioka, M.; Kanzaki, S.; Ogawa, K. The autophagy pathway
maintained signaling crosstalk with the Keap1ꢀNrf2 system through
p62 in auditory cells under oxidative stress. Cell. Signal. 2015, 27,
J.ꢀP.; Yonchuk, J. G.; Feldser, H. G.; Sanchez, Y.; Foley, J. P.;
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
Bolognese, B. J.; Logan, G.; Podolin, P. L.; Yan, H.; Callahan, J. F.;
Heightman, T. D.; Kerns, J. K. Monoacidic inhibitors of the Kelchꢀ
like ECHꢀassociated protein 1: nuclear factor erythroid 2ꢀrelated
factor 2 (KEAP1:NRF2) protein–protein interaction with high cell
potency identified by fragmentꢀbased discovery. J. Med. Chem. 2016,
59, 3991ꢀ4006.
(24) Jiang, Z. Y.; Xu, L. L.; Lu, M. C.; Chen, Z. Y.; Yuan, Z. W.;
Xu, X. L.; Guo, X. K.; Zhang, X. J.; Sun, H. P.; You, Q. D. Structureꢀ
activity and structureꢀproperty relationship and exploratory in vivo
evaluation of the nanomolar Keap1ꢀNrf2 proteinꢀprotein interaction
inhibitor. J. Med. Chem. 2015, 58, 6410ꢀ6421.
(25) Bertrand, H. C.; Schaap, M.; Baird, L.; Georgakopoulos, N.
D.; Fowkes, A.; Thiollier, C.; Kachi, H.; DinkovaꢀKostova, A. T.;
Wells, G. Design, synthesis, and evaluation of triazole derivatives that
induce Nrf2 dependent gene products and inhibit the Keap1ꢀNrf2
proteinꢀprotein interaction. J. Med. Chem. 2015, 58, 7186ꢀ7194.
(26) Winkel, A. F.; Engel, C. K.; Margerie, D.; Kannt, A.; Szillat,
H.; Glombik, H.; Kallus, C.; Ruf, S.; Gussregen, S.; Riedel, J.;
Herling, A. W.; von Knethen, A.; Weigert, A.; Brune, B.; Schmoll, D.
Characterization of RA839, a noncovalent small molecule binder to
Keap1 and selective activator of Nrf2 signaling. J. Biol. Chem. 2015,
290, 28446ꢀ28455.
(27) Wen, X.; Thorne, G.; Hu, L.; Joy, M. S.; Aleksunes, L. M.
Activation of NRF2 signaling in HEK293 cells by a firstꢀinꢀclass
direct KEAP1ꢀNRF2 inhibitor. J. Biochem. Mol. Toxicol. 2015, 29,
261ꢀ266.
(28) Lu, M.ꢀC.; Yuan, Z.ꢀW.; Jiang, Y.ꢀL.; Chen, Z.ꢀY.; You, Q.ꢀ
D.; Jiang, Z.ꢀY. A systematic molecular dynamics approach to the
study of peptide Keap1ꢀNrf2 proteinꢀprotein interaction inhibitors and
its application to p62 peptides. Mol. Biosyst. 2016, 12, 1378ꢀ1387.
(29) Lu, M.ꢀC.; Chen, Z.ꢀY.; Wang, Y.ꢀL.; Jiang, Y.ꢀL.; Yuan, Z.ꢀ
W.; You, Q.ꢀD.; Jiang, Z.ꢀY. Binding thermodynamics and kinetics
guided optimization of potent Keap1ꢀNrf2 peptide inhibitors. RSC
Advances 2015, 5, 85983ꢀ85987.
(30) Lo, S.ꢀC.; Li, X.; Henzl, M. T.; Beamer, L. J.; Hannink, M.
Structure of the Keap1:Nrf2 interface provides mechanistic insight
into Nrf2 signaling. EMBO J. 2006, 25, 3605ꢀ3617.
(31) Padmanabhan, B.; Tong, K. I.; Ohta, T.; Nakamura, Y.;
Scharlock, M.; Ohtsuji, M.; Kang, M.ꢀI.; Kobayashi, A.; Yokoyama,
S.; Yamamoto, M. Structural basis for defects of Keap1 activity
provoked by its point mutations in lung cancer. Mol. Cell 2006, 21,
689ꢀ700.
(
3
82ꢀ393.
(10) Jiang, Z.ꢀY.; Xu, L.ꢀL.; Lu, M.ꢀC.; Pan, Y.; Huang, H.ꢀZ.;
Zhang, X.ꢀJ.; Sun, H.ꢀP.; You, Q.ꢀD. Investigation of the
intermolecular recognition mechanism between the E3 ubiquitin
ligase Keap1 and substrate based on multiple substrates analysis. J.
Comput.-Aided Mol. Des. 2014, 28, 1233ꢀ1245.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
(
11) Niture, S. K.; Jaiswal, A. K. Hsp90 interaction with
INrf2(Keap1) mediates stressꢀinduced Nrf2 activation. J. Biol. Chem.
010, 285, 36865ꢀ36875.
12) Clements, C. M.; McNally, R. S.; Conti, B. J.; Mak, T. W.;
2
(
Ting, J. P. DJꢀ1, a cancerꢀ and Parkinson's diseaseꢀassociated protein,
stabilizes the antioxidant transcriptional master regulator Nrf2. Proc.
Natl. Acad. Sci. U. S. A. 2006, 103, 15091ꢀ15096.
(13) Jiang, Z.ꢀY.; Chu, H.ꢀX.; Xi, M.ꢀY.; Yang, T.ꢀT.; Jia, J.ꢀM.;
Huang, J.ꢀJ.; Guo, X.ꢀK.; Zhang, X.ꢀJ.; You, Q.ꢀD.; Sun, H.ꢀP. Insight
into the intermolecular recognition mechanism between Keap1 and
IKKβ combining homology modelling, proteinꢀprotein docking,
molecular dynamics simulations and virtual alanine mutation. PLoS
One 2013, 8, e75076.
(14) Lee, D. F.; Kuo, H. P.; Liu, M.; Chou, C. K.; Xia, W.; Du, Y.;
Shen, J.; Chen, C. T.; Huo, L.; Hsu, M. C.; Li, C. W.; Ding, Q.; Liao,
T. L.; Lai, C. C.; Lin, A. C.; Chang, Y. H.; Tsai, S. F.; Li, L. Y.;
Hung, M. C. KEAP1 E3 ligaseꢀmediated downregulation of NFꢀ
kappaB signaling by targeting IKKbeta. Mol. Cell 2009, 36, 131ꢀ140.
(
15) Abed, D. A.; Goldstein, M.; Albanyan, H.; Jin, H.; Hu, L.
Discovery of direct inhibitors of Keap1ꢀNrf2 proteinꢀprotein
interaction as potential therapeutic and preventive agents. Acta Pharm
Sin B 2015, 5, 285ꢀ299.
(
16) Richardson, B. G.; Jain, A. D.; Speltz, T. E.; Moore, T. W.
Nonꢀelectrophilic modulators of the canonical Keap1/Nrf2 pathway.
Bioorg. Med. Chem. Lett. 2015, 25, 2261ꢀ2268.
(17) Jiang, Z.ꢀY.; Lu, M.ꢀC.; Xu, L. L.; Yang, T.ꢀT.; Xi, M.ꢀY.;
Xu, X.ꢀL.; Guo, X.ꢀK.; Zhang, X.ꢀJ.; You, Q.ꢀD.; Sun, H.ꢀP.
Discovery of potent Keap1–Nrf2 protein–protein interaction inhibitor
based on molecular binding determinants analysis. J. Med. Chem.
2
014, 57, 2736ꢀ2745.
18) Jain, A. D.; Potteti, H.; Richardson, B. G.; Kingsley, L.;
(
Luciano, J. P.; Ryuzoji, A. F.; Lee, H.; Krunic, A.; Mesecar, A. D.;
Reddy, S. P.; Moore, T. W. Probing the structural requirements of
nonꢀelectrophilic naphthaleneꢀbased Nrf2 activators. Eur. J. Med.
Chem. 2015, 103, 252ꢀ268.
(32) Fukutomi, T.; Takagi, K.; Mizushima, T.; Ohuchi, N.;
Yamamoto, M. Kinetic, thermodynamic, and structural
characterizations of the association between Nrf2ꢀDLGex degron and
Keap1. Mol. Cell. Biol. 2014, 34, 832ꢀ846.
(33) Marcotte, D.; Zeng, W.; Hus, J.ꢀC.; McKenzie, A.; Hession,
C.; Jin, P.; Bergeron, C.; Lugovskoy, A.; Enyedy, I.; Cuervo, H.;
Wang, D.; Atmanene, C.; Roecklin, D.; Vecchi, M.; Vivat, V.;
Kraemer, J.; Winkler, D.; Hong, V.; Chao, J.; Lukashev, M.; Silvian,
L. Small molecules inhibit the interaction of Nrf2 and the Keap1
Kelch domain through a nonꢀcovalent mechanism. Bioorg. Med.
Chem. 2013, 21, 4011ꢀ4019.
(
19) Jnoff, E.; Albrecht, C.; Barker, J. J.; Barker, O.; Beaumont, E.;
Bromidge, S.; Brookfield, F.; Brooks, M.; Bubert, C.; Ceska, T.;
Corden, V.; Dawson, G.; Duclos, S.; Fryatt, T.; Genicot, C.; Jigorel,
E.; Kwong, J.; Maghames, R.; Mushi, I.; Pike, R.; Sands, Z. A.;
Smith, M. A.; Stimson, C. C.; Courade, J. P. Binding mode and
structureꢀactivity relationships around direct inhibitors of the Nrf2ꢀ
Keap1 complex. Chemmedchem 2014, 9, 699ꢀ705.
(
20) Zhuang, C.; Narayanapillai, S.; Zhang, W.; Sham, Y. Y.;
(34) Goldhahn, H. Darstellung des 4ꢀNitronaphthylaminꢀ1. J.
Prakt. Chem. 1940, 156, 315ꢀ316.
Xing, C. Rapid identification of Keap1ꢀNrf2 smallꢀmolecule
inhibitors through structureꢀbased virtual screening and hitꢀbased
substructure search. J. Med. Chem. 2014, 57, 1121ꢀ1126.
(35) Stanley, M.; Martin, S. R.; Birge, M.; Carbain, B.; Streicher,
H. Biotinꢀ, fluoresceinꢀ and 'clickable' conjugates of phosphaꢀ
oseltamivir as probes for the influenza virus which utilize selective
binding to the neuraminidase. Org. Biomol. Chem. 2011, 9, 5625ꢀ9.
(36) Rich, R. L.; Myszka, D. G. Higherꢀthroughput, labelꢀfree,
realꢀtime molecular interaction analysis. Anal. Biochem. 2007, 361, 1ꢀ
6.
(37) Wysocki, L. M.; Lavis, L. D. Advances in the chemistry of
small molecule fluorescent probes. Curr. Opin. Chem. Biol. 2011, 15,
752ꢀ759.
(
21) Hu, L.; Magesh, S.; Chen, L.; Wang, L.; Lewis, T. A.; Chen,
Y.; Khodier, C.; Inoyama, D.; Beamer, L. J.; Emge, T. J.; Shen, J.;
Kerrigan, J. E.; Kong, A. N.; Dandapani, S.; Palmer, M.; Schreiber, S.
L.; Munoz, B. Discovery of a smallꢀmolecule inhibitor and cellular
probe of Keap1ꢀNrf2 proteinꢀprotein interaction. Bioorg. Med. Chem.
Lett. 2013, 23, 3039ꢀ3043.
(
22) Sun, H.ꢀP.; Jiang, Z.ꢀY.; Zhang, M.ꢀY.; Lu, M.ꢀC.; Yang, T.ꢀ
T.; Pan, Y.; Huang, H.ꢀZ.; Zhang, X.ꢀJ.; You, Q.ꢀd. Novel proteinꢀ
protein interaction inhibitor of Nrf2ꢀKeap1 discovered by structureꢀ
based virtual screening. MedChemComm 2014, 5, 93ꢀ98.
(23) Davies, T. G.; Wixted, W. E.; Coyle, J. E.; GriffithsꢀJones, C.;
Hearn, K.; McMenamin, R.; Norton, D.; Rich, S. J.; Richardson, C.;
Saxty, G.; Willems, H. M. G.; Woolford, A. J. A.; Cottom, J. E.; Kou,
(38) Chen, X.; Pradhan, T.; Wang, F.; Kim, J. S.; Yoon, J.
Fluorescent chemosensors based on spiroringꢀopening of xanthenes
and related derivatives. Chem. Rev. 2012, 112, 1910ꢀ1956.
ACS Paragon Plus Environment